4//SEC Filing
LEXICON PHARMACEUTICALS, INC./DE 4
Accession 0001127602-14-005344
$LXRXCIK 0001062822operating
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 4:12 PM ET
Size
7.6 KB
Accession
0001127602-14-005344
Insider Transaction Report
Form 4
ZAMBROWICZ BRIAN P
EVP, Chief Scientific Officer
Transactions
- Award
Restricted Stock Units (Phantom Stock)
2014-02-06+85,000→ 85,000 total→ Common Stock (85,000 underlying) - Award
Stock Option (Right to Buy)
2014-02-06+340,000→ 340,000 totalExercise: $1.72Exp: 2024-02-06→ Common Stock (340,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2015 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.
- [F3]Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/6/15) and vests 1/48th per month for each month of service thereafter.
Documents
Issuer
LEXICON PHARMACEUTICALS, INC./DE
CIK 0001062822
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001062822
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 4:12 PM ET
- Size
- 7.6 KB